Free shipping on all orders over $ 500

GSK-2330672 (Linerixibat)

Cat. No. M10322

All AbMole products are for research use only, cannot be used for human consumption.

GSK-2330672 (Linerixibat) Structure
Synonym:

Linerixibat

Size Price Availability Quantity
1mg USD 100  USD100 In stock
5mg USD 270  USD270 In stock
10mg USD 440  USD440 In stock
25mg USD 890  USD890 In stock
50mg USD 1400  USD1400 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GSK-2330672, also known as linerixibat, is a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (IC50 = 42 nM) for the research of type 2 diabetes. In vivo, Linerixibat (0.05-10 mg/kg; oral gavage; twice daily for 14 days) treatment on male ZDF rat lowers glucose in an animal model of type 2 diabetes.

Chemical Information
Molecular Weight 546.68
Formula C28H38N2O7S
CAS Number 1345982-69-5
Form Solid
Solubility (25°C) DMSO 37 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Yifeng Wang, et al. Gene Expr. HNF4α Regulates CSAD to Couple Hepatic Taurine Production to Bile Acid Synthesis in Mice

[2] Yulin Wu, et al. J Med Chem. Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes

Related Sodium Channel Products
5-(N,N-Hexamethylene)-amiloride

5-(N,N-Hexamethylene)-amiloride (Hexamethylene amiloride) is a potent Na+/H+ exchanger inhibitor, which decreases the intracellular pH (pHi) and induces apoptosis in leukemic cells. 5-(N,N-Hexamethylene)-amiloride (Hexamethylene amiloride) is also an inhibitor of the HIV-1 Vpu virus ion channel and inhibits mouse hepatitis virus (MHV) replication and human coronavirus 229E (HCoV229E) replication in cultured L929 cells with EC50s of 3.91 μM and 1.34 μM, respectively.

HwTx-IV

Huwentoxin-IV (HwTx-IV) is a 35-residue neurotoxin peptide with potential application as a novel analgesic. Huwentoxin-IV, a component of tarantula venom, potently blocks sodium channels and is an attractive scaffold for engineering a Nav1.7-selective molecule.

ST-2560

ST-2560 is a selective inhibitor of the NaV1.7 sodium channel with IC50 value of 39 nM in primates with ≥1000-fold selectivity over other isoforms of the human NaV1.x family.

A-317567 

A-317567 is a potent acid-sensing ion channel 3 (ASIC-3) inhibitor with an IC50 of 1.025 μM.

XPC-6444 

XPC-6444 is a highly potent, isoform-selective, and CNS-penetrant NaV1.6 inhibitor (IC50=41 nM for hNaV1.6).

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK-2330672 (Linerixibat), Linerixibat supplier, Sodium Channel, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.